Results 91 to 100 of about 29,455 (302)

Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease

The Prostate, EarlyView.
ABSTRACT Background Prostate cancer (PCa) is the most common solid organ cancer in men and the fifth leading cause of cancer‐related deaths globally. PSA helps identify men at risk but has low specificity and has resulted in unnecessary biopsies. The PROSTest, a novel machine learning‐based 27‐gene mRNA liquid biopsy assay, was developed to detect PCa.
Mark Kidd, Grzegorz Rempega, Michal Kepinski, Szymon Slomian, Krystyna Mlynarek, Abdel B. Halim   +5 more
wiley   +1 more source

Factors Influencing Continued Usage of Intracavernosal Injections for Erectile Dysfunction: A Retrospective Analysis

The World Journal of Men's Health
Purpose: Intracavernosal injections are used to treat erectile dysfunction. Patient compliance with intracavernosal injections is required for success, though factors influencing compliance are unknown.
Braian Rene Ledesma, Jason Codrington, David Velasquez, Alexandra Aponte Varnum, Joshua White, Greeshma Venigalla, Farah Rahman, Katherine Campbell, Alexander Weber, Max Sandler, Ranjith Ramasamy   +10 more
doaj   +1 more source

NÍVEIS PERIFÉRICOS DE TESTOSTERONA TOTAL EM TOUROS GUZERÁ

Ciência Animal Brasileira, 2014
Twenty-four Guzerat bulls were evaluated from 24 to 34 months of age, aiming to determinate the bulls serum testosterone concentration profile and their variation according to age, body weight and andrologic traits.
Juliano Cesar Dias, Venício José de Andrade, Lucas Luz Emerick, Jorge André Matias Martins, Vicente Ribeiro do Vale Filho   +4 more
doaj   +1 more source

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer

The Prostate, EarlyView.
ABSTRACT Objective To evaluate the value of circulating free DNA (cfDNA) in prostate cancer (PCa) by cfDNA assay and analysis of plasma and urinary cfDNA fragmentation to determine the usefulness of this parameter for risk staging and tumor progression monitoring.
Marta Victoria Lorenzo‐Sánchez, José Miguel Giménez‐Bachs, María Granada Picazo‐Martínez, María José Donate‐Moreno, Carlos Martínez‐Sánchiz, María Amalia Tárraga‐Honrubia, Sonsoles Navarro‐Jiménez, Óscar Legido‐Gómez, Antonio Santiago Salinas‐Sánchez   +8 more
wiley   +1 more source

ANDROLOGY LAB CORNER*: One Semen Sample or 2? Insights From a Study of Fertile Men [PDF]

, 2007
Abbie Stokes‐Riner, Sally W. Thurston, Charlene Brazil, David S. Guzick, Fan Liu, James W. Overstreet, Christina Wang, Amy E. Sparks, J. Bruce Redmon, Shanna H. Swan   +9 more
openalex   +1 more source

Long‐Term Follow‐Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial

The Prostate, EarlyView.
ABSTRACT Introduction Neoadjuvant intense androgen deprivation therapy (ADT) with androgen receptor signaling inhibitors (ARSIs) has shown pathologic complete responses (pCR) in prostate cancer (PCa), but long‐term survival outcomes remain unclear. This study evaluates the durability of response following neoadjuvant ADT plus enzalutamide before robot ...
Braden Millan, Nikhil Pramod, Ruben Blachman‐Braun, Jaskirat Saini, Lauren Loebach, Milan Patel, Sandeep Gurram, Baris Turkbey, Fatima Karzai, Peter A. Pinto   +9 more
wiley   +1 more source

Is It Time for Andrology and Endocrinology Professionals in Assisted Reproduction Centers?

, 2023
Rossella Cannarella, Marta Marino, Rosita A. Condorelli, Sandro La Vignera, Aldo E. Calogero   +4 more
openalex   +1 more source

Unveiling the potential of emerging microRNA panels as diagnostic biomarkers for prostate cancer: A review

UroPrecision, EarlyView.
Abstract Prostate cancer (PCa) is a multifaceted disease that envelops 1.41 million new cases globally. It is the second most common cancer reported in men. Its heterogeneity and indolent growth, coupled with incompetent early screening methods such as serum prostate‐specific antigen level estimations and digital rectal examinations, contribute to its ...
Anveshika Manoj, Gautam Prasad, Mohammad Kaleem Ahmad   +2 more
wiley   +1 more source

Revised guidelines for human embryology and andrology laboratories [PDF]

, 2006

openalex   +1 more source

Exome‐wide molecular insights from blood and urine liquid biopsies in genitourinary cancers

UroPrecision, EarlyView.
Abstract Background Liquid biopsy has emerged as a non‐invasive method for real‐time cancer monitoring especially in genitourinary (GU) oncology. Most current studies utilize a panel‐based molecular profiling ranging from 50–600 genes; however, a comprehensive exome‐wide profiling of real‐world patient samples has been lacking. Methods Over 2000 liquid
Eric Jia, Tiantian Zheng, Yong Huang, Pan Du   +3 more
wiley   +1 more source